Predictors of the presence and extent of peripheral arterial occlusive disease

Circulation

Volumn 94, Issue 9 SUPPL., 1996, Pages

  Drexel, Heinz ^a   Steurer, Johann ^a   Muntwyler, Jörg ^a   Meienberg, Sigrid ^a   Schmid, Hans Ruedi ^b   Schneider, Ernst ^a   Gröchenig, Ernst ^a   Amann, Franz W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

atherosclerosis; cholesterol; lipoproteins; peripheral vascular disease

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CORONARY ARTERY BLOOD FLOW; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; TRIGLYCERIDES;

EID: 0343438377     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis: lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med. 1983;309:288-296.
2. Tyroler HA. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation. 1987;76:515-522.
3. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet. 1975;1:16-19.
4. Gordon DJ, Rifkind BM. High density lipoprotein: the clinical implication of recent studies. N Engl J Med. 1989;321:1311-1316.
5. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986;256:2835-2838.
6. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 1992;70:733-737.
7. Pilger E, Pristautz H, Pfeiffer KP, Kostner G. Risk factors for peripheral atherosclerosis: retrospective evaluation by stepwise discriminant analysis. Arterioscler Thromb. 1993;3:57-63.
8. Umemoto T. Serum lipids and lipoproteins in peripheral vascular disease. Nippon Geka Gakkai Zasshi. 1985;86:84-97.
9. Pauciullo P, Carlson LA, Eklund B, Johansson J, Olsson AG. Concentration and chemical composition of plasma lipoprotein subfractions in patients with peripheral vascular disease: evidence for normal apolipoprotein B but low cholesterol ester content in small VLDL. Atherosclerosis. 1985;58:123-137.
10. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol. 1995;15:441-445.
11. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, Ruckley CV. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992;135:331-340.
12. Senti M, Nogues X, Pedor-Botet J, Rubies-Prat J, Vidal-Barraquer F. Lipoprotein profile in men with peripheral vascular disease: role of intermediate density lipoproteins and apoprotein E phenotypes. Circulation. 1992;85:30-36.
13. Nogues X, Senti M, Pedro-Botet J, Rubies-Prat J, Vidal-Barraquer F, Senti M. Serum lipoprotein(a) levels in men with peripheral vascular disease. Angiology. 1991;42:659-664.
14. Patsch JR, Gotto AM Jr. Metabolism of high density lipoproteins. In: Gotto AM, ed. Plasma Lipoproteins. Amsterdam, Netherlands: Elsevier Science Publishing Co; 1987:221-259.
15. Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The Mean, Arteries and Veins. 7th ed. New York, NY: McGraw-Hill Publishing Co; 1990:378-384.
16. Grundy S. Disorders of lipids and lipoproteins. In: Stein JH, ed. Internal Medicine. 2nd ed. Boston, Mass: Little & Brown; 1987: 2035-2052.
17. 3 cholesterol, apo A-I and apo A-II, and increased risk of myocardial infarction. Circulation. 1992;85:22-29.
18. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
19. Alessandri C, Violi F, De Marzio E, Caliendo C, Votano R, Cordova C, Balsano F. Blood lipid abnormalities in patients suffering from peripheral vascular disease. Int Angiol. 1988;7:263-265.
20. 3-cholesterol in normolipemic patients with peripheral vascular occlusive disease. Vasa. 1986;15:217-219.
21. Austin MA. Plasma triglyceride and coronary artery disease. Arterioscler Thromb. 1991;11:2-13.
22. Vogelberg KH, Grimm K, Ones FA. Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular disease. Harm Metab Res. 1995;15(suppl):90-94.
23. Drexel H, Amann FW, Beran J, Rentsch K, Candinas R, Muntwyler J, Luethy A, Gasser T, Follath F. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation. 1994;90: 2230-2235.
24. Hosmer DW, Lemshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989:140-145.
25. 2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A. 1978;75:4519-4523.
26. Miesenböck G, Hölzl B, Föger B, Brandstätter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91:448-455.
27. Drexel H, Amann FW, Rentsch K, Neuenschwander C, Luethy A, Khan SI, Follath F. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol. 1992;70:436-440.
28. Johnson WJ, Mahrlberg FH, Rothblat GH, Phillips MC. Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta. 1991;1085:273-298.
29. Huang Y, von Eckardstein A, Assmann G. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb. 1993;13:445-458.
30. Davidson WS, Sparks DL, Lund-Katz S, Phillips MC. The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins. J Biol Chem. 1994;269:8959-8965.
31. Parthasarathy S, Barnett J, Fong LG. High density lipoprotein inhibits the oxidative modification of low density lipoproteins. Biochim Biophys Acta. 1990;1044:275-283.
32. Mackness MI, Abbott CA, Arrol S, Durrington PN. The role of high density lipoprotein and lipid soluble anti-oxidant vitamins in inhibiting low density lipoprotein oxidation. Biochem J. 1993;294:829-834.
33. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 1987;84:2995-2998.
34. Steurer J, Drexel H, Khan SI, Schneider E, Amann FW, Bollinger A. Reversal of atherosclerotic obstructions by percutaneous transluminal angioplasty raises high-density lipoprotein cholesterol. Vasa. 1995; 24:15-18.
35. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
36. Brewer HB Jr, Zech LA, Gregg RE, Schwartz D, Schaefer EJ. NIH conference: type III hyperlipoproteinemia - diagnosis, molecular defects, pathology, and treatment. Ann Intern Med. 1983;98:623-640.
37. Dortimer AC, Shenoy PN, Shiroff RA, Leaman DM, Babb JD, Liedtke AJ, Zelis R. Diffuse coronary artery disease in diabetic patients: fact or fiction? Circulation. 1978;57:133-136.
38. Kukita H, Imamura Y, Hamada M, Joh T, Kokubu T. Plasma Iipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives. Atherosclerosis. 1982;42:21-29.
39. Reed D. Which risk factors are associated with atherosclerosis? Circulation. 1993;87(suppl II):II-54-II-55.